Patients Deserve Price Tags Act

U.S. Congress · HR5582 · In Committee

What the bill says

HR5582 · U.S. Congress · In Committee

Introduced 2025-09-26. Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

View on Congress.gov →

Sponsors

Text versions

  • Introduced in House — 2025-09-26 — XML

What analysts say

No nonpartisan analysis on file for this measure yet.

What politicians say

No linked claims or utterances yet — no one on record has cited this measure to justify a public argument.

Action History

DateAction
2025-09-26Introduced in House
2025-09-26Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Lobbying on this bill

Showing 25 of 81 bill mentions.

Honesty note: each filer below disclosed lobbying on this bill — that much the filing tells us. But the dollar figure is their total lobbying spend for the whole quarter across all their issues, not the amount spent on this bill, and the filing never says whether they supported or opposed it.

Registrant (lobbying firm)ClientPeriodReported quarterly amountExtraction
SMALL BUSINESS MAJORITY FOUNDATION, INC. SMALL BUSINESS MAJORITY FOUNDATION, INC. Q2 2026 not reported Explicit
ARENTFOX SCHIFF LLP TRANSPARENCY-RX CORP. Q2 2026 $20,000 Explicit
LABORATORY CORPORATION OF AMERICA HOLDINGS LABORATORY CORPORATION OF AMERICA HOLDINGS Q2 2026 $270,000 Explicit
CHRISTIANACARE CHRISTIANACARE Q2 2026 not reported Explicit
CHRISTIANACARE CHRISTIANACARE Q2 2026 not reported Explicit
THE NICKLES GROUP, LLC AMERICAN HOSPITAL ASSOCIATION Q2 2026 $90,000 Explicit
COLLEGE OF AMERICAN PATHOLOGISTS COLLEGE OF AMERICAN PATHOLOGISTS Q2 2026 $180,107 Explicit
NATIONWIDE CHILDREN'S HOSPITAL, INC. NATIONWIDE CHILDREN'S HOSPITAL INC Q2 2026 $80,000 Explicit
NATIONWIDE CHILDREN'S HOSPITAL, INC. NATIONWIDE CHILDREN'S HOSPITAL INC Q2 2026 $80,000 Explicit
CHARTWELL STRATEGY GROUP LLC METRIPORT INC. Q2 2026 $60,000 Explicit
ARENTFOX SCHIFF LLP TRANSPARENCY RISING CORP. Q2 2026 not reported Explicit
AMERICAN CLINICAL LABORATORY ASSN AMERICAN CLINICAL LABORATORY ASSN Q2 2026 $890,000 Explicit
MEHLMAN CONSULTING, INC. HOUSTON METHODIST HOSPITAL Q2 2026 $50,000 Explicit
CLARITEV (FORMERLY MULTIPLAN CORPORATION) CLARITEV (FORMERLY MULTIPLAN CORPORATION) Q2 2026 $130,000 Probable
THE NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATION NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATION Q2 2026 $140,000 Explicit
ASSOCIATION OF AMERICAN MEDICAL COLLEGES ASSOCIATION OF AMERICAN MEDICAL COLLEGES Q2 2026 $821,438 Explicit
ARENTFOX SCHIFF LLP TRANSPARENCY RISING CORP. Q2 2026 not reported Explicit
INDIANA FEDERAL AFFAIRS STATE OF INDIANA Q2 2026 $75,000 Probable
TIBER CREEK GROUP CIGNA CORPORATION AND SUBSIDIARIES Q2 2026 $90,000 Explicit
ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG) PURCHASER BUSINESS GROUP ON HEALTH (PBGH) Q2 2026 $20,000 Explicit
MONUMENT ADVOCACY COUNCIL FOR AFFORDABLE HEALTH COVERAGE Q2 2026 $30,000 Explicit
HIGHMARK, INC. HIGHMARK INC Q2 2026 $230,000 Explicit
AMERICAN BENEFITS COUNCIL AMERICAN BENEFITS COUNCIL Q2 2026 $214,000 Probable
NATIONAL BEER WHOLESALERS ASSOCIATION NATIONAL BEER WHOLESALERS ASSOCIATION Q2 2026 $530,000 Explicit
THE NEW YORK AND PRESBYTERIAN HOSPITAL NEW YORK AND PRESBYTERIAN HOSPITAL Q2 2026 $130,000 Explicit

Source: Senate LDA filings.